147 related articles for article (PubMed ID: 33173994)
21. [Expression of NUF2 in breast cancer and its clinical significance].
Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425
[TBL] [Abstract][Full Text] [Related]
22. Silencing of NUF2 inhibits proliferation of human osteosarcoma Saos-2 cells.
Fu HL; Shao L
Eur Rev Med Pharmacol Sci; 2016; 20(6):1071-9. PubMed ID: 27049259
[TBL] [Abstract][Full Text] [Related]
23. Validating linalool as a potential drug for breast cancer treatment based on machine learning and molecular docking.
Zhang Q; Chen D
Drug Dev Res; 2024 Jun; 85(4):e22223. PubMed ID: 38879780
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
25. Effects of cisplatin on the proliferation, invasion and apoptosis of breast cancer cells following β‑catenin silencing.
Zhu X; Feng J; Fu W; Shu X; Wan X; Liu J
Int J Mol Med; 2020 Jun; 45(6):1838-1850. PubMed ID: 32186756
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of WWP2 suppresses proliferation, and induces G1 cell cycle arrest and apoptosis in liver cancer cells.
Xu SQ; Qin Y; Pan DB; Ye GX; Wu CJ; Wang S; Jiang JY; Fu J; Wang CJ
Mol Med Rep; 2016 Mar; 13(3):2261-6. PubMed ID: 26783238
[TBL] [Abstract][Full Text] [Related]
27. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
[TBL] [Abstract][Full Text] [Related]
28. BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer.
Mo Q; Xu K; Luo C; Zhang Q; Wang L; Ren G
Biochem Biophys Res Commun; 2021 May; 553():17-24. PubMed ID: 33756341
[TBL] [Abstract][Full Text] [Related]
29. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
30. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
31. miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN.
Xiao S; Zhu H; Luo J; Wu Z; Xie M
Oncol Rep; 2019 Dec; 42(6):2550-2560. PubMed ID: 31638259
[TBL] [Abstract][Full Text] [Related]
32. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
[TBL] [Abstract][Full Text] [Related]
34. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.
Zhu T; Ji Z; Xu C; Peng Z; Gu L; Zhang R; Liu Y
J Mol Histol; 2014 Dec; 45(6):665-77. PubMed ID: 25027991
[TBL] [Abstract][Full Text] [Related]
37. ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
Shatnawi A; Ayoub NM; Alkhalifa AE
Clin Breast Cancer; 2021 Aug; 21(4):e319-e331. PubMed ID: 33334698
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
39. WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.
Zhou Q; Chen X; He H; Peng S; Zhang Y; Zhang J; Cheng L; Liu S; Huang M; Xie R; Lin T; Huang J
Theranostics; 2021; 11(10):4809-4824. PubMed ID: 33754029
[No Abstract] [Full Text] [Related]
40. RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth.
Yan F; Wang X; Zhu M; Hu X
Oncol Rep; 2016 Nov; 36(5):2793-2799. PubMed ID: 27666310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
